Immix Biopharma, Inc. (IMMX) vs Tactile Systems Technology, Inc. (TCMD)
A side-by-side comparison of Immix Biopharma, Inc. and Tactile Systems Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMMX
Immix Biopharma, Inc.
$9.60HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
TCMD
Tactile Systems Technology, Inc.
$22.14HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — IMMX vs TCMD
growth of $100 · dividends reinvested · last 5yIMMX +176.0% (+22.5%/yr)TCMD +14.1% (+2.7%/yr)IMMX compounded faster over this window
IMMX TCMD
IMMX vs TCMD: by the numbers
- •IMMX is the larger company ($523M vs $499M market cap).
- •TCMD is profitable (7.10% net margin) while IMMX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | IMMX | TCMD |
|---|---|---|
| P/E ratio | N/A | 20.50 |
| Forward P/E | N/A | 19.83 |
| P/S ratio | N/A | 1.43 |
| P/B ratio | 2.28 | 2.23 |
| EV / EBITDA | N/A | 10.64 |
| FCF yield | N/A | 5.35% |
Profitability
| Metric | IMMX | TCMD |
|---|---|---|
| Gross margin | 0.00% | 74.23% |
| Operating margin | 0.00% | 10.00% |
| Net margin | 0.00% | 7.10% |
| ROE | -17.44% | 11.11% |
| ROIC | -18.20% | 9.54% |
Growth (annualized)
| Metric | IMMX | TCMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 11.62% |
| FCF CAGR (5Y) | N/A | 32.09% |
| Total return CAGR (5Y) | N/A | -11.73% |
Frequently asked
- Is IMMX or TCMD more profitable?
- TCMD runs the higher net margin — IMMX at 0.00% versus TCMD at 7.10%.
Go deeper
Dig into the metrics
Tactile Systems Technology P/E ratioImmix Biopharma ROETactile Systems Technology ROEImmix Biopharma operating marginTactile Systems Technology operating marginImmix Biopharma revenue growthTactile Systems Technology revenue growthImmix Biopharma free cash flowTactile Systems Technology free cash flow
Immix Biopharma & Tactile Systems Technology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.